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In this work, the authors prepared and characterized two different graphene oxides: one chemically synthesized (GO sample) and
the other one electrochemically synthesized (GO(LiCl)). Both samples were fully characterized with atomic force microscopy (AFM),
Raman and Fourier transform infrared (FTIR) spectroscopies, X-ray photo electron spectroscopy (XPS), thermal analysis
(TG/DTA), and Z-potential. The antibacterial properties of both graphene oxides were studied using Gram-negative Escherichia
coli ATCC 25922 and Gram-positive Staphylococcus aureus ATCC 25923 by spectrophotometer and viable cell count as indirect
and direct methods, respectively. Results demonstrated that the GO(LiCl) exhibited a significant antibacterial activity compared to
GO that showed a bacteriostatic effect on both pathogens. Electron microscopy analysis confirmed the antibacterial effects of both
graphene oxides toward the pathogens, especially working at 80 μg/mL, for 24h. Additional studies were also performed and both
GO samples were not cytotoxic at 2 μg/mL toward neuroblastoma cells. Moreover, 2 μg of GO was suitable to carry the minimum
effective dose (5.74 ng/mL) of kinase inhibitor S29 (1-(2-chloro-2-(4-chlorophenyl)ethyl)-N-(4-fluorobenzyl)-1H-pyrazolo[3,4-d]
pyrimidin-4-amine), providing negligible side effects related to the S29 treatment (this latter being specifically active on the
neuroblastoma cell lines (SK-N-BE(2))).
1. Introduction
One of the most important research field applications for
medicine focuses on new therapeutic agents’ delivery tools,
with the first aim to improve therapy efficiency. Recent
advances in the nanomaterial field provide useful biocom-
patible nanostructured materials and nanocomposites, suit-
able for drug delivery systems. Among all the innovative
materials, graphene derivatives [1] have attracted a great
deal of scientific interest in biomedicine and pharmacology
sciences. Graphene, a single layer of sp2-hybridized carbon
atoms arranged in a honeycomb two-dimensional (2-D)
crystal lattice, exhibits excellent chemical-physical, biochem-
ical [2], mechanical, and engineering properties, extremely
useful for several applications in sensors [3] and optoelec-
tronic devices [4], environmental monitoring tools [5], food
quality control [6], and medical devices [7]. With particular
regard to the fields of application that include food quality
control and medicine field applications, the antibacterial fea-
tures [8] and the biocompatibility properties toward the real
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matrixes (as food or normal human cell lines, organic tissue,
and blood) represent a key point that nanomaterials must
possess. There are several cases of study, described in litera-
ture by interesting review articles concerning the improved
antibacterial activity [9] and the increased biocompatibility
[10] properties, exhibited by the graphene derivatives. These
last properties mainly depend on the synthesis routes
applied for graphene production [11]. According to this,
Valentini et al. [12] recently report about a metal-free
green graphene oxide (GO(LiCl)), synthesized by the elec-
trochemical exfoliation of micrometric graphite electrodes
(2015 patent no. 102015000023739). GO(LiCl) was fully
characterized, resulting in antibacterial material, and
finally applied for in vitro cellular experiments, to establish
its biocompatibility [12]. The novelty of this work consists
of a new green chemistry synthetic route (under patent)
for the fabrication of GO samples. The latter showed a
bacteriostatic activity (if compared with the bactericidal
action, exhibited by GO(LiCl)), in the presence of both path-
ogens, as the Gram-negative E. coli ATCC 25922 and the
Gram-positive S. aureus ATCC 25923. A cytotoxicity assay
was performed, in order to identify in GO a new promising
nanocarrier for compound S29: 1-(2-chloro-2-(4-chlorophe-
nyl)ethyl)-N-(4-fluorobenzyl)-1H-pyrazolo[3,4-d]pyrimidi-
n-4-amine, therapeutic agent. The scientific interest on S29
as a therapeutic agent consists of its ability to reduce tumor
mass in neuroblastoma xenograft mice models. For this pur-
pose, in this study the SK-N-BE(2) neuroblastoma cell lines
were used for the cytotoxicity investigation, concerning the
S29 therapeutic anticancer agent. S29 shows an unfavorable
pharmacokinetic profile, causing a limited use in the treat-
ment of cancer. Until now, in literature, liposomes [13]
and human serum albumin (HSA) [14] have been applied
to improve S29 delivery, biodistribution, and bioavailabil-
ity but the concentration of liposomes and HAS nanopar-
ticles had to be very high and this leads to significant high
cytotoxicity in vitro and in vivo [13, 14] experiments.
Instead, in this work, it has been shown that graphene
derivatives were not cytotoxic and they could be used at
extremely low levels of concentration, if compared with
those applied in the presence of liposomes and HAS nano-
particles. In particular, according to the results exhibited
by the GO samples, this latter seems to be more eligible
for S29 delivery.
2. Materials and Methods
2.1. Chemicals. The electrochemically grown graphene oxide
sample (labelled as GO(LiCl)) was obtained by a patented
synthetic approach, as widely reported in a 2015 patent (no.
102015000023739) and also in reference [12]. For the chem-
ical synthesis of the graphene oxide (labelled as GO), a new
wet mechanic-chemical exfoliation synthesis was developed
by the same authors of this work, and now it is under patent.
The other chemicals used in the analysis were purchased
from Sigma-Aldrich (USA). All reagents were of analytical
grade and used as received without further purification.
The procedure of preparing GO and GO(LiCl) nanosheet
dispersions was similar for the cytotoxicity and antibacterial
tests, except that GO suspension was carried out by using
phosphate-buffered saline (PBS) for the cytotoxicity analysis
and by using a saline solution 0.9% (10mL) in the case of the
antibacterial tests. The finial graphene oxide dispersions
were transparent, and they were very well dispersed by son-
ication with a polytronic probe, at room temperature.
2.2. Material Characterization. The AFMmeasurements were
performed in air using a Veeco Multiprobe IIIa instrument
(Veeco, Santa Barbara, CA, USA). The GO was deposited
using an aqueous solution on the mica substrates. The exper-
iments were carried out at room temperature (20°C) in tap-
ping mode using Si tips with a spring constant of about
40N/m and a typical curvature radius on the tip of 7nm.
The XPS measurements were carried out using an Omicron
DAR 400 Al/Mg Kα nonmonochromatic X-ray source and a
VG-CLAM2 electron spectrometer. GO (1mg/mL) was very
well dispersed in ethanol using an ultrasonic probe and then
deposited on the silicon wafer. ζ-potential was determined
by Dynamic Light Scattering (DLS) (Zetasizer Nano ZS90,
Malvern Instruments Ltd., Malvern, UK). Graphene oxide
samples were diluted in water, providing an optical density
(OD) of 0.1 at 420nm, and then measured at 24° C with a
scattering angle of 90°. ζ-potential measurements were carried
out using folded capillary cells (Malvern). Thermogravimetric
analysis was carried out by a Q600 thermogravimetric ana-
lyzer (TA Instruments-Waters, USA). Samples (~20mg) were
put in a platinum crucible and heated from 30°C to 700°C,
with a rate of 10°C/min, under nitrogen purge gas.
2.3. Cytotoxicity Tests: Cell Culture. The long-term neuro-
blastoma cell lines, SH-SY5Y and SK-N-BE(2) (ACC no.
209 and ACC no. 632, respectively), obtained from DSMZ,
Braunschweig, Germany, in October 2012, were maintained
in RPMI 1640 (Gibco, Grand Island, NY, USA) with or with-
out phenol red, supplemented with heat-inactivated 10%
FCS containing 2mM L-glutamine. Preliminary time and
concentration course experiments with GO 0.57, 5.74, and
57.4 μg/mL were performed in our laboratory in order to
establish the conditions at which GO did not cause cell
necrosis. Cell vitality was monitored before each experiment
by a trypan blue (Sigma-Aldrich) [15] exclusion assay, in
which dead cells are stained and those with intact membranes
are not. Briefly, cell viability was determined using the trypan
blue exclusion test. SK-N-BE(2) cells (5×104/mL) were sus-
pended in a 10 μL suspension containing trypan blue (0.4%
w/v; Sigma-Aldrich) in phosphate-buffered saline (PBS) and
incubated at room temperature for 5min, followed by exami-
nation under a light microscope to determine the percent-
age of cells with clear (viable cells) and blue (nonviable
cells) cytoplasm.
2.4. Antibacterial Activity. GO or GO(LiCl) (2mg) were dis-
persed in saline solution 0.9% (10mL) by sonication with a
polytronic probe. The suspensions were sterilized by
autoclaving, at 121°C for 15min, before being inoculated
with bacteria to reach a final concentration ranging from
20 to 80 μg/mL. Staphylococcus aureus subspecies aureus
derived from ATCC 25923 and Escherichia coli derived from
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ATCC 25922 were purchased from Microbiologics (USA).
Tryptic Soy Broth (TSB) was purchased from VWR Prolabo
Chemicals (Italy) and prepared as reported in data sheet.
Nutrient Agar with NaCl was purchased from BioLife (Italy)
and prepared as reported in product information. Saline
solution 0.9% (NaCl: VWR Prolabo Chemicals, Italy) was
prepared dissolving 9 g of NaCl in 1000mL of distilled water,
sterilized by autoclaving at 121°C for 15min. E. coli (ATCC
25922) and S. aureus (ATCC 25923) were used to perform
viability tests. Bacteria were grown in TSB medium at 37°C
overnight, and cells were collected via centrifugation
(4000 rpm for 20min). The cells were washed three times
with sterile saline solution to remove residual macromole-
cules and other growth medium constituents. The pellets
were then suspended in saline solution at 0.9% [16, 17]. Bac-
terial cell suspensions were diluted in NaCl 0.9% to obtain
cell samples having an optical density at 600nm (OD600) at
T0 corresponding to 10
7-108 CFU/mL (OD600 =0.4 for S.
aureus and OD600 =0.3 for E. coli). Cells were incubated
with different concentrations (20, 40, and 80 μg/mL) of
GO or GO(LiCl) at 37
°C for 4 hours (T1) and 24 hours (T2
). The untreated samples with E. coli or S. aureus were used
as the control. Growth of treated and untreated samples
were followed by measuring OD at 600nm with spectropho-
tometer NANOCOLOR UV/VIS II (MACHEREY-NAGEL,
Germany), at 1-hour intervals for 6 hours and then after
24 hours of treatment. The viability was evaluated by the
colony-counting method. Briefly, bacterial amount at the
starting time (T0), after 4 hours of treatment (T1), and after
24 hours (T2) was determined by performing a series of
10-fold cell dilutions (100 μL each) that were spread onto
Nutrient Agar plates and allowed to grow overnight at
37°C. Colonies were counted and compared with those on
control plates to calculate the change in cell growth inhibi-
tion. The antibacterial activity was expressed as a function
of cell viability loss; the loss of cell viability (%) was deter-
mined by using the number of colonies found in the exper-
imental mixture incubated with GO and the number of
colonies found in the “inoculum only,” incubated without
GO. All the experiments were done in duplicate, and the
average values were reported. For SEM (FE-SEM Quanta
Inspect F, FEI, Thermo Fisher Scientific) analysis, a steady
state culture of E. coli (ATCC 29522) and S. aureus (ATCC
29523), grown in LB at 37°C o.n., was washed in physiolog-
ical saline solution and incubated with GO or GO(LiCl)
80 μg/mL, for 8 and 24 hours at 37°C. Successively, samples
were fixed with 2.5% glutaraldehyde in 0.1M sodium caco-
dylate buffer and were left to adhere on poly-lysine-treated
glass coverslips for 4 hours at room temperature (RT) and
o.n. at 4°C. Then, adhered bacteria were washed and post-
fixed with 1% OsO4 in 0.1M sodium cacodylate buffer for
1 h at RT and dehydrated through a graded series of ethanol
solutions (from 30% to 100%), according to reference [18].
For TEM (EM 208S transmission electron microscope, FEI,
Thermo Fisher, equipped with the acquisition system Olym-
pus MegaView SIS camera, at 100 kV) analysis, the same
bacterial cultures were fixed in 2.5% glutaraldehyde, 2%
paraformaldehyde, and 2mM CaCl2 in 0.1M sodium caco-
dylate buffer, pH7.4, overnight at 4°C, and were processed
according to Perry and Gilbert [19]. Samples were washed
in cacodylate buffer and postfixed with 1% OsO4 in 0.1M
sodium cacodylate buffer for 1 hour at RT, treated with 1%
tannic acid for 30min and rinsed in 1% sodium sulphate,
for 10min. Postfixed specimens were washed, dehydrated
through a graded series of ethanol solutions (30–100% etha-
nol), and embedded in Agar 100 (Agar Scientific Ltd., UK).
3. Results and Discussion
3.1. Characterization of GO Samples. These two graphene
oxide samples were synthesized by a chemical and electro-
chemical synthesis pathway, respectively, and fully charac-
terized by using AFM, EDAX, and XPS techniques. The
Table 1: Chemical-physical parameters and microanalysis of the graphene oxide samples.
Sample Shape Thickness (nm) Area (μm2) Microanalysis % (w/w)
Chemically synthesized GO Rectangular nanosheets
1 5 ± 0 4
No. layers: 2-3
6× 10-2 - 0.1
Si, S, Ca, Cr, Fe, Co
n.d.
Electrochemically synthesized GO Rectangular nanosheets
1 2 ± 0 3
No. layers: 2
0.1-3.0
Si, S, Ca, Cr, Fe, Co
n.d.
n.d.: not detectable.
Table 2: Binding Energies (BE) and deconvoluted peaks (%) for C1s
of GO.
Peak BE (eV) C1s At. % Functional groups
284.4 59.0 C-C
285.4 16.0 C-OH
286.6 14.0 C-O
287.7 7.0 C =O
289.0 4.0 C(O)O
290.7 2.2 π-π∗
π-π∗ : means the π-bonding orbital and the π∗-antibonding orbital.
Table 3: Binding Energies and deconvoluted peaks (%) for C1s of
GO(LiCl).
Peak BE (eV) C1s At. % Functional groups
283.6 23.50 C-C
284.6 36.50 C-OH
285.5 21.70 C-O
286.5 18.30 C =O
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main characterization results have been highlighted in
Tables 1, 2, and 3. In Table 1, it is possible to recognize that
the two kinds of graphene oxide samples were very similar in
thickness and number of layers; on the other hand, chem-
ically synthesized graphene (GO) had a lower surface area
value, if compared with that exhibited by the electrochem-
ically synthesized graphene sample (GO(LiCl)). Instead, as
regards the content of metals, the microanalysis (EDAX)
unequivocally showed that the metal content resulted
below the detection limit of the microanalysis technique,
indicating that both these GO samples were metal-free
graphene-based nanomaterials.
XPS analysis was carried out to study the chemical
shift of GO samples. The C1s XPS core level spectrum
analysis of GOs with the corresponding quantitative
parameters is shown in Table 2 (for GO) and Table 3
(for GO(LiCl)). From Table 2, it is possible to observe that
the chemically synthesized graphene oxide sample results
are more oxidized, with a greater presence of carbonyl
and/or carboxylic functional groups, if compared with
those exhibited by the graphene synthesized by the electro-
chemical route strategy (see also Table 3). The electro-
chemically synthesized graphene sample results in a more
reduced C1s chemical shift (i.e., less oxidized if compared
to the chemical shift of graphene obtained by chemical
synthesis approach).
The functionalization degree and the chemical shift of
graphene oxide samples certainly represent very useful
parameters, strictly related to the antibacterial activity and
biocompatibility properties. According to the literature
[20], the oxygenated functional groups are firstly responsible
for the antibacterial behavior of GO nanosheets. The mech-
anism underlying this feature involved the generation of
reactive oxygen species (ROS), able to provoke the oxidative
stress through an electronic transfer mechanism. Function-
alities strictly influence the electronic and/or electron-
transfer processes, especially since graphene oxide shows a
more insulating profile, when compared with pristine
(metallic behavior) and reduced graphene sheets (semicon-
ductor-semimetal transitions with reduction). The electro-
nic/electron-transfer interaction mechanisms mainly occur
between the positively charged Gram-negative E. coli and
the negatively charged GO and GO(LiCl), preferentially. In
the case of the Gram-positive S. aureus (having negatively
charged bacterial walls), the semiconductive properties of
GO(LiCl) could provoke a greater electrostatic repulsion
(when compared to the insulating GO), because it delivers
a greater electron density, toward the negatively charged S.
aureus pathogen walls (and the electron-transfer mecha-
nism is discussed in detail in Results and Discussion,
Section 3 of this paper).
Several authors affirmed that the antibacterial features
of nanomaterials are also the result of a complex interac-
tion between two main additional factors: size and shape.
Liu et al. [21] demonstrated that the antibacterial activity
of GO sheets toward E. coli cells is lateral size dependent.
Larger GO sheets show stronger antibacterial activity than
smaller ones, and they have different time- and
concentration-dependent antibacterial features. The same
authors [21] described that the lateral size-dependent
antibacterial properties of GO sheets are caused by nei-
ther their aggregation states nor oxidation ability. Large
GO sheets more easily cover cells, and cells cannot prolif-
erate once fully covered, resulting in the cell viability loss,
experimentally observed in the following colony-
countingtest. In contrast, small GO sheets adhere to
the bacterial surfaces, which cannot effectively isolate
cells from the environment.
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Figure 1: FTIR spectra profiles for both GO derivatives.
Table 4: Physical properties of the graphene oxide samples.
Sample
Weight loss %
(TGA)a
Acidic sites
(nmol/mg)b
Extent of defects
(ID/IG)
c, Raman
GO 0 88 ± 0 23 9 45 ± 0 20 0.42
GO(LiCl) 0 42 ± 0 40 4 02 ± 0 23 0.10
aMean ± SD. bAcidic sites evaluated as described in [29, 30] (Mean ± SD), by
volumetric titration. cEvaluated by Raman spectroscopy.
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As far as the form is concerned, it is stated in the literature
that the geometries/shapes of both nanomaterials and bacteria
are fundamental to guarantee the mutual interaction of the
two systems. In particular, Akhavan et al. [22] affirmed that
the graphene nanoribbons showed much higher cytotoxicity
than the graphene sheets. The ROS (Radical Oxygenated Spe-
cies) generation and direct contact interaction of the extremely
sharp edges of graphene with the membrane of the cells were
found as the main mechanisms involved in the cytotoxicity of
both shapes of graphene: nanoribbons and nanosheets [22].
Moreover, the shape of the bacteria is also relevant. Hui
et al. [23] report about diverse Graphene Quantum Dots
(GQDs) with basal planes similar to those of graphene oxide
sheets lacking an antibacterial property, which is prepared by
rupturing the C60 cage which effectively kills Staphylococcus
aureus, including its antibiotic-tolerant persisters, but not
Bacillus subtilis, Escherichia coli, or Pseudomonas aeruginosa.
The observed activity may correlate with a GQD’s ability to dis-
rupt the bacterial cell envelope and is the initial step for cell
envelope disruption, suggesting the importance of GQDs’
chemical composition and shapes.
The same parameters (i.e., mainly the functionalization
degree, size, and shape/geometries) also influence the bio-
compatibility of graphene and GO derivatives. In particular,
the functionalization seems to be the required/necessary
condition to achieve the highest biocompatibility for nano-
materials [24] because they provide oxygenated bridges, very
useful in establishing covalent and/or electrostatic interac-
tions with biopolymers and biomolecules. This strategy
focuses on the fabrication of several different biocompatible
coatings; surrounding the nanostructured material surfaces,
edges, and sides; and increasing their biocompatibility
towards cells and tissues.
There is also a first level of functionalization degree,
which is absent in biopolymers and present only in
as-deposited GO and GO derivatives (this latter as
post-synthesis treated carbon-based graphene materials).
In this case, the only presence of the oxygenated func-
tional groups on the GO surface mainly provides a better
dispersibility in the working medium [25]. A stable nano-
dispersion, in liquid phase, offers two important advan-
tages during the experiments:
(a) (b)
Figure 2: TEM micrographs of (a) GO and (b) GO(LiCl).
Control sample
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Figure 3: Growth curves of SK-N-BE(2), treated with GO (2.0μg/mL) and S29 10 μM, 72 h. RSD< 3%.
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(1) Graphene nanosheets are more easily distributed in
the cellular compartments, avoiding aggregation and
their subsequent expulsion by gravimetric settling
(2) Graphene nanodispersion phases improve safety bio-
distribution processes [26] into the cells, minimizing
the ROS generation mechanisms very well. This is
especially due to the establishment of the couple elec-
trostatic interactions between the oxygenated func-
tional groups (mainly C(=O)OH, C(=O)R, C(=O)H,
OH, etc.) and the aqueous working medium. The
couple interactions strongly compete with the side
reactions, involved in the formation of ROS radicals,
since the electrostatic interactions, established with
solvent-working medium, thermodynamically stabi-
lize the resulting nanodispersion systems [27, 28]
According to the main importance of the functionali-
zation degree on the GO properties and performances,
FTIR spectra profiles (see Figure 1), TG/DTA, and Raman
results (these latter reported in Table 4) were also inserte-
d/included in the manuscript, in order to confirm the XPS
data analysis. Moreover, the acidic site evaluation
(nmol/mg), reported in Table 4, mainly quantifies the
C(=O)OH functional groups. These latter were also detected
by using the Z-potential measurement technique that
revealed negative values of -28.7mV for GO and -32.1mV
for GO(LiCl) (typically achieved when in the presence of the
negatively charged carboxylate anions C(=O)O-).
Furthermore, TEM analysis (Figure 2) confirmed the
presence of more defective structures in the case of the most
oxidized sample, as GO. This latter appeared as a multilayer
of graphene oxide (A), while GO(LiCl) showed a more regular
shape/geometry of the resulting nanosheets, similar to that
exhibited by the pristine single layer of graphene.
3.2. Cytotoxicity: Evaluation of Cellular Proliferation. Cell
growth curves in Figure 3 show that there is a decrease in
growth rate during exposure to 2μg/mL GO for 24 and 48
hours compared to controls. Cell mortality rate, detected by
trypan blue dye, was between 4% and 6%. We had previously
established that higher doses of GO (10 and 20μg) were cyto-
toxic for SK-N-BE(2) cells but 2μg/mL GO did not induce
cell damage, so this concentration of GO provided the right
concentration for carrying the minimum toxic concentration
of S29. Treatment of cells with 10μM S29 and 2μg/mL GO
started to inhibit cell growth after 24 h of exposure and
became significantly different from GO alone or S29 alone
at 48 h and 72h. 10nM and 100 nMS29 with, respectively,
5.74 ng/mL and 57.4 ng/mL GO failed to induce significant
cell growth inhibition after 24 h from addition to cultures,
meaning that S29 has a very low cytotoxicity in SK-N-BE(2)
cells. In particular, these optimized concentration values for
both the nanocarrier and S29 therapeutic agent were the low-
est results compared to those declared in literature [31].
Moreover, the same authors [31] do not load drugs but only
evaluate the cytotoxicity of the GO-Ag nanocarrier, at the
(a) (b)
(c)
Figure 4: Optical microscopy of SK-N-BE(2) treated with 2.0 μg/mL of GO+ 10 μM of S29, at (a) 24 h, magnification 20x; (b) 24 h,
magnification 60x; (c) 48 h, magnification 60x (May Grunwald Giemsa staining).
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highest concentration values in cells. Cell counts with trypan
blue exclusion test demonstrated a low rate of cell necrosis
even after 72 h of culture with 10μMS29 and 2μg GO, mean-
ing that the inhibition of cell growth may be probably due to
longer cell cycles or induction of apoptosis (the trypan blue
data were also confirmed by the LDH assay, carried out as
previously reported in reference [12]). Observation of cell
cultures (40x inverted microscopy) showed that cells did
not change their morphology nor detach from plastic after
treatments (Figure 4).
3.3. Antibacterial Activity. Figures 5 and 6 showed the growth
curves of GO-treated and GO(LiCl)-treated E. coli and S.
aureus bacterial cells, respectively. Both treated bacteria grew
following the trend exhibited by the corresponding control
samples. When the bacteria cells were incubated with differ-
ent graphene oxide concentrations, a significant reduction of
the OD values was recorded (if compared to the controls,
reported in Figures 5(b) and 5(d) and Figures 6(b) and
6(d)). Results indicated that the bacteria cells exhibited a
reduction of their growth, proportionally to the GO concen-
trations. This agreed with the literature [32] where the lower
sizes of GO sheets adhered on the bacteria surfaces, without
isolating them from the nutrient environment. Increasing
the GO concentrations, bacteria cell results were more cov-
ered, effectively isolated from the environment and con-
demned to die. The bacteria cells, treated with GO(LiCl),
exhibited a significant reduction to their growth, already at
the lowest concentrations and independent of the GO(LiCl)
concentrations. This could be explained considering the larg-
est area of GO(LiCl) (Table 1), which was suitable to cover the
external surface of the bacteria cells, provoking the indirect
toxicity by biologically isolating them from the growth
medium. Consequently, the bacterial cells could neither pro-
liferate nor consume the nutrients and died. The death rate of
the bacteria was determined by the colony-counting method.
Figure 7 showed that both GO and GO(LiCl) reduced the
growth of the S. aureus and E. coli (over 90%), when bacteria
were exposed to different concentrations of graphene oxides,
at T1 = 4 h. The E. coli control samples at T0 were
1.9× 108UFC/mL, and after 4 h, the control increased up
to 1.25× 109CFU/mL. After 4 h, the E.coli cells grew up
to 1.64× 108 (at 20μg/mL of GO), 1.13× 108 (at 80μg/mL
of GO), 1.22× 108 (at 20μg/mL of GO(LiCl)), and
1.01× 108CFU/mL (at 80μg/mL of GO(LiCl)). At T0, the con-
trol sample for S. aureus was 3.8× 107CFU/mL, and after 4 h,
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Figure 5: OD (a, c) and turbidimetric assay (b, d) of the two different GO incubated with E. coli at different times and concentrations.
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the control increased up to 1.53× 108UFC/mL. S. aureus-
treated cells, at T1, grew up to 7.27× 10
6 (at 80μg/mL of
GO), 1.85× 107 (at 20μg/mL of GO), 2.32× 106 (at 80μg/mL
of GO(LiCl)), and 9.64× 10
6CFU/mL (at 20μg/mL of
GO(LiCl)). After 24 hours (T2), the experimental results
showed that E. coli control increased up to 1.35× 108. The
cells grew up to 9.52× 107 (at 80μg/mL of GO), reaching
the value of 1.03× 108 (at 20μg/mL of GO). Incubating E. coli
with GO(LiCl), cells grew up to 7.14× 10
7 (at 80μg/mL
GO(LiCl)) and reached the values of 9.30× 10
7CFU/mL (at
20μg/mL GO(LiCl)). In the case of S. aureus, the control
increased up to 1.41× 105. The treated S. aureus cells grew
up to 5.38× 104 (at 80μg/mL of GO), 5.72× 104 (at 20μg/mL
of GO), 3.91× 104 (at 80μg/mL of GO(LiCl)), and
5.64× 104CFU/mL (at 20μg/mL of GO(LiCl)). The antibacte-
rial effects on E. coli were highly evident at 4 hours, with a
growth reduction of 90%, for both GO samples. At 24 hours,
the antibacterial activity for E. coli in the presence of GO(LiCl)
(Figure 8(a)) was superior to GO and also higher if compared
with S. aureus. A reasonable explanation could be the pres-
ence of a much thinner peptidoglycan wall, in the E. coli
structure [31]. For S. aureus, the antibacterial effects were
observed at T1 = 4 hours, with a bacterial growth reduction
of 95%. At 24 hours, the bacterial cell growth reduction was
about 60%, working with GO, and slightly higher (75%)
in the presence of GO(LiCl) (Figure 8(b)). After 24 h of
GO incubation, S. aureus showed a typical bacteriostatic
activity, if compared with E. coli. The experimental results
could be explained as a combination of different parame-
ters [33], such as the bacteria morphology/structure [34,
35] and the conductivity behavior of the GO [36] (more
insulating nanomaterial) and GO(LiCl) [37] (a semiconduc-
tive material), these latter being responsible for the
electron-transfer interaction between the graphene deriva-
tives and the bacteria cells.
To examine whether direct interaction of bacteria and
graphene oxide nanosheets could exhibit a key role in the
antibacterial activity of graphene oxide (80μg/mL), the mor-
phological changes of both bacterial cells, S. aureus and E.
coli, were studied using SEM and TEM analysis, respectively.
E. coli control exhibited normal rod-like morphology with
regular and intact membranes (Figure 9(a)). E. coli incu-
bated with GO exhibited severe membrane deformations,
and cell shape was seriously distorted with evident shrinkage
effects (Figure 9(b)). These effects could be probably due to a
collapse of the internal structure. In some cases, the outer
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Figure 6: OD (a, c) and turbidimetric assay (b, d) of the two different GOs incubated with S. aureus at different times and concentrations.
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membranes merged with those belonging to the other bacte-
ria cells (Figure 9(c)). E. coli, when incubated with GO(LiCl),
also exhibited similar behavior (Figures 9(d) and 9(e)). The
experimental results could be explained considering a typical
electron-transfer process from the positively charged
Gram-negative E. coli and the negatively charged GO
and GO(LiCl) nanomaterials. The results could be inter-
preted considering a synergy of effects such as an electron
transfer [38] (from graphene oxide toward the bacterial
membranes), the oxidative stress [39], and the mechanical
tearing (cutting effect depending on the shape and size of
the graphene nanosheets).
In the case of S. aureus cells, SEM micrographs showed a
regular sphere shape (Figure 9(f), inset) and a typical
grape-like aggregation in the entire control sample
(Figure 9(f), the main image). When S. aureus cells were
incubated with 80μg/mL of GO (24 h), they showed a lightly
irregular and shrunken shape (Figure 9(g)). The graphene
oxide-bacteria interactions developed strong forces of attrac-
tion among cells that induced the formation of numerous
spherical bacterial aggregates around graphene oxide nano-
sheets (Figure 9(h)), which are completely absent in the case
of E. coli, when incubated with the same GO. This result
could be explained when considering a strong electrostatic
interaction between the Gram-positive S. aureus (with an
isoelectric point [40] pI = 2~3, versus pI = 4-5 in the case
of E. coli [41]) and the more insulating GO nanomaterial.
When inoculated with GO(LiCl), the aggregation effects were
also recorded (Figures 9(i) and 9(j)) in S. aureus cells but
much less evident than those shown in Figure 9(h), for
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Figure 7: E. coli cell viability at 4 h (a) and 24 h (b). S. aureus cell viability at 4 h (c) and 24 h (d).
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GO. The explanation could be related to the semiconductive
properties of GO(LiCl) that could provoke a greater electro-
static repulsion, because it delivers more electrons toward
the negatively charged bacterial walls, as in the case of the
S. aureus pathogen (with the result of decreasing the value
of the electrostatic potential membrane ΔE/V). TEM analy-
sis confirmed that the direct contact of the graphene oxide
nanosheets with bacterial cells induced the loss of the struc-
tural integrity, in both bacterial species and the presence of
both GO samples. TEM micrographs of E. coli exposed to
GO for 24h showed that the bacterial shrinkage, observed
by SEM, was consistent with plasma membrane damage
and retraction, leading to the leakage of intracellular mate-
rial in the periplasmic space (Figures 10(b) and 10(c) versus
Figure 10(a) that is the control). Therefore, it is reasonable to
think that an electron-transfer process can be triggered, fol-
lowing the breaking of the membrane and consequent leak-
age of periplasmic materials. The effective and irreversible
damages of the bacterial cells could happen after the elec-
tronic transfer processes, in combination with the oxidative
stress or additional mechanical tearing processes [42]. In
Figure 10(c), the “insertion/cutting mode” interaction
between GO and E. coli clearly highlighted a nanosheet while
it entered into the phospholipid bilayer, cutting the mem-
brane (Figure 10(c)), as reported in literature [43]. Similar
profiles were detected incubating E. coli with GO(LiCl) nano-
sheets (Figures 10(d) and 10(e)). S. aureus, incubated with
80μg/mL of GO for 24h, showed numerous contacts with
GO, with a great number of cells characterized by several
types of plasma membrane damage, having significant con-
densation of the intracellular material [44] (Figure 10(g) ver-
sus the unaltered control in Figure 10(f)). The initial plasma
membrane damage evolved in the leakage of intracellular
material and the loss of cell wall integrity (Figure 10(h)), pro-
voking the cell death. A similar trend was observed when S.
aureus was incubated with GO(LiCl), where the cell damage
seemed to be related to the electron diffusion mechanisms,
from the graphene nanosheets toward the bacterial plasma
membranes, which is especially more significant for the
semimetallic graphene (GO(LiCl)) samples (Figures 10(i)
and 10(j)). Concerning the antibacterial activity, it is neces-
sary to underline that both types of graphene intrinsically
exhibited this property [31] without the synergy with a tra-
ditional antibacterial agent, such as the silver element.
4. Conclusions
In this study, two different metal-free graphene oxide
products were synthesized, by using chemical and electro-
chemical procedures. The resulting graphene oxides
showed different functionalization degrees (mainly as
C(=O)OH groups), which determined different electronic
features: a semiconductive behavior in the presence of
GO(LiCl) and a more insulating profile in the case of chem-
ically synthesized GO. These features could explain the
slightly different reactivity, observed working with GO
and GO(LiCl) in bacteria and in neuroblastoma cells,
respectively. In particular, both graphene oxides (2μg/mL)
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Figure 8: Growth reduction (%) of E. coli (a) and S. aureus (b) in the presence of GO or GO(LiCl).
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showed a negligible effect of cytotoxicity, being eligible as a
carrier of the S29 compound. Furthermore, both graphene
oxides possess an interesting antimicrobial activity, especially
GO(LiCl) which resulted in a bactericidal agent, and GO was a
bacteriostatic ecofriendly nanomaterial. In particular, this
last feature represents an important biocompatibility prop-
erty that elects the GO as the new nanovector of anticancer
drugs, especially in neuroblastoma cell lines.
Data Availability
The data used to support the findings of this study are
included within the article.
Conflicts of Interest
The authors declare no competing financial interest.
Acknowledgments
The work was financially supported by the Smart Campus
Project (CUP E82I15000980002). The authors also wish to
thank Professor Silvia Schenone from the Department of
Pharmacy, Università degli Studi di Genova, Viale Benedetto
XV, 3, 16132, Genova (IT), for technical support.
References
[1] A. Jafarizad, A. Taghizadehgh-Alehjougi, M. Eskandani et al.,
“PEGylated graphene oxide/Fe3O4 nanocomposite: synthesis,
characterization, and evaluation of its performance as de novo
drug delivery nanosystem,” Bio-medical Materials and Engi-
neering, vol. 29, no. 2, pp. 177–190, 2018.
[2] Kenry, W. C. Lee, K. P. Loh, and C. T. Lim, “When stem cells
meet graphene: opportunities and challenges in regenerative
medicine,” Biomaterials, vol. 155, pp. 236–250, 2018.
[3] Y. Wu, B. Yao, C. Yu, and Y. Rao, “Optical graphene gas sen-
sors based on microfibers: a review,” Sensors, vol. 18, no. 4,
pp. 941–957, 2018.
[4] F.-X. Liang, Y. Gao, C. Xie, X.-W. Tong, Z.-J. Li, and L.-B. Luo,
“Recent advances in the fabrication of graphene–ZnO
heterojunctions for optoelectronic device applications,” Jour-
nal of Materials Chemistry C, vol. 6, no. 15, pp. 3815–3833,
2018.
[5] M. A. Kang, S. Ji, S. Kim et al., “Highly sensitive and wearable
gas sensors consisting of chemically functionalized graphene
oxide assembled on cotton yarn,” RSC Advances, vol. 8,
no. 22, pp. 11991–11996, 2018.
[6] Y. Chyan, R. Ye, Y. Li, S. P. Singh, C. J. Arnusch, and J. M.
Tour, “Laser-induced graphene by multiple lasing: toward
electronics on cloth, paper, and food,” ACS Nano, vol. 12,
no. 3, pp. 2176–2183, 2018.
[7] S. Afsahi, M. B. Lerner, J. M. Goldstein et al., “Novel
graphene-based biosensor for early detection of Zika virus
infection,” Biosensors and Bioelectronics, vol. 100, pp. 85–88,
2018.
[8] P. Choudhary, T. Parandhaman, B. Ramalingam,
N. Duraipandy, M. S. Kiran, and S. K. Das, “Fabrication of
nontoxic reduced graphene oxide protein nanoframework as
sustained antimicrobial coating for biomedical application,”
ACS Applied Materials & Interfaces, vol. 9, no. 44,
pp. 38255–38269, 2017.
[9] S. P. Singh, Y. Li, A. Be’er, Y. Oren, J. M. Tour, and C. J.
Arnusch, “Laser-induced graphene layers and electrodes pre-
vents microbial fouling and exerts antimicrobial action,” ACS
Applied Materials & Interfaces, vol. 9, no. 21, pp. 18238–
18247, 2017.
[10] X. Zhao, Z. Wei, Z. Zhao et al., “Design and development of
graphene oxide nanoparticle/chitosan hybrids showing
pH-sensitive surface charge-reversible ability for efficient
intracellular doxorubicin delivery,” ACS Applied Materials &
Interfaces, vol. 10, no. 7, pp. 6608–6617, 2018.
[11] J. Sturala, J. Luxa, M. Pumera, and Z. Sofer, “Chemistry of gra-
phene derivatives: synthesis, applications, and perspectives,”
Chemistry - A European Journal, vol. 24, no. 23, pp. 5992–
6006, 2018.
[12] F. Valentini, E. Mari, A. Zicari et al., “Metal free graphene
oxide (GO) nanosheets and pristine-single wall carbon nano-
tubes (p-SWCNTs) biocompatibility investigation: a compara-
tive study in different human cell lines,” International Journal
of Molecular Sciences, vol. 19, no. 5, p. 1316, 2018.
[13] M. Celano, S. Schenone, D. Cosco et al., “Cytotoxic effects of a
novel pyrazolopyrimidine derivative entrapped in liposomes
in anaplastic thyroid cancer cells in vitro and in xenograft
(i) (j)
Figure 10: TEMmicrographs of antibacterial effect of GO and GO(LiCl) on E. coli and S. aureus: (a) E. coli control; (b, c) E. coli incubated with
80μg/mL of GO at 24 h; (d, e) E. coli incubated with 80μg/mL of GO(LiCl) at 24 h; (f) S. aureus control; (g, h) S. aureus incubated with
80μg/mL of GO at 24 h; (i, j) S. aureus incubated with 80μg/mL of GO(LiCl) at 24 h.
13Journal of Nanomaterials
tumors in vivo,” Endocrine-Related Cancer, vol. 15, no. 2,
pp. 499–510, 2008.
[14] A. L. Fallacara, A. Mancini, C. Zamperini et al., “Pyrazo-
lo[3,4-d]pyrimidines-loaded human serum albumin (HSA)
nanoparticles: preparation, characterization and cytotoxicity
evaluation against neuroblastoma cell line,” Bioorganic &
Medicinal Chemistry Letters, vol. 27, no. 14, pp. 3196–3200,
2017.
[15] E. Mari, A. Zicari, F. Fico, I. Massimi, L. Martina, and
S. Mardente, “Action of HMGB1 on miR-221/222 cluster in
neuroblastoma cell lines,” Oncology Letters, vol. 12, no. 3,
pp. 2133–2138, 2016.
[16] S. A. Wells Jr and M. Santoro, “Update: the status of clinical
trials with kinase inhibitors in thyroid cancer,” The Journal
of Clinical Endocrinology & Metabolism, vol. 99, no. 5,
pp. 1543–1555, 2014.
[17] S. Martina Ferrari, C. La Motta, S. Sartini et al., “Pyrazolopyr-
imidine derivatives as antineoplastic agents: with a special
focus on thyroid cancer,” Mini-Reviews in Medicinal Chemis-
try, vol. 16, no. 2, pp. 86–93, 2015.
[18] L. Bertuccini, R. Russo, F. Iosi, and F. Superti, “Effects of Lacto-
bacillus rhamnosus and Lactobacillus acidophilus on bacterial
vaginal pathogens,” International Journal of Immunopathology
and Pharmacology, vol. 30, no. 2, pp. 163–167, 2017.
[19] M. M. Perry and A. B. Gilbert, “Yolk transport in the ovarian
follicle of the hen (Gallus domesticus): lipoprotein-like parti-
cles at the periphery of the oocyte in the rapid growth phase,”
Journal of Cell Science, vol. 39, pp. 257–272, 1979.
[20] S. Bykkam, K. V. Rao, C. H. S. Chakra, and T. Thunugunta,
“Synthesis and characterization of graphene oxide and its anti-
microbial activity against Klebseilla and Staphylococus,” Inter-
national Journal of Advanced Biotechnology and Research,
vol. 4, pp. 1005–1009, 2013.
[21] S. Liu, M. Hu, T. H. Zeng et al., “Lateral dimension-dependent
antibacterial activity of graphene oxide sheets,” Langmuir,
vol. 28, no. 33, pp. 12364–12372, 2012.
[22] O. Akhavan, E. Ghaderi, H. Emamy, and F. Akhavan, “Geno-
toxicity of graphene nanoribbons in human mesenchymal
stem cells,” Carbon, vol. 54, pp. 419–431, 2013.
[23] L. Hui, J. Huang, G. Chen, Y. Zhu, and L. Yang, “Antibacterial
property of graphene quantum dots (both source material and
bacterial shape matter),” ACS Applied Materials & Interfaces,
vol. 8, no. 1, pp. 20–25, 2016.
[24] K. Yang, Y. Li, X. Tan, R. Peng, and Z. Liu, “Behavior and tox-
icity of graphene and its functionalized derivatives in biologi-
cal systems,” Small, vol. 9, no. 9-10, pp. 1492–1503, 2013.
[25] D. Konatham and A. Striolo, “Molecular design of stable gra-
phene nanosheets dispersions,” Nano Letters, vol. 8, no. 12,
pp. 4630–4641, 2008.
[26] X. Zhang, J. Yin, C. Peng et al., “Distribution and biocom-
patibility studies of graphene oxide in mice after intrave-
nous administration,” Carbon, vol. 49, no. 3, pp. 986–995,
2011.
[27] S. Vesaratchanon, A. Nikolov, and D. T. Wasan, “Sedimenta-
tion in nano-colloidal dispersions: effects of collective interac-
tions and particle charge,” Advances in Colloid and Interface
Science, vol. 134-135, pp. 268–278, 2007.
[28] T. Kuila, S. Bose, A. K. Mishra, P. Khanra, N. H. Kim, and J. H.
Lee, “Chemical functionalization of graphene and its applica-
tions,” Progress in Materials Science, vol. 57, no. 7, pp. 1061–
1105, 2012.
[29] Y. S. Kim and C. R. Park, “One-pot titration methodology for
the characterization of surface acidic groups on functionalized
carbon nanotubes,” Carbon, vol. 96, pp. 729–741, 2016.
[30] S. Visentin, N. Barbero, S. Musso et al., “Sensitive and practical
fluorimetric test for CNT acidic site determination,” Chemical
Communications, vol. 46, pp. 1443–1445, 2010.
[31] W. Shao, X. Liu, H. Min, G. Dong, Q. Feng, and S. Zuo, “Prep-
aration, characterization, and antibacterial activity of silver
nanoparticle-decorated graphene oxide nanocomposite,” ACS
Applied Materials & Interfaces, vol. 7, no. 12, pp. 6966–6973,
2015.
[32] S. Jaworski, M. Wierzbicki, E. Sawosz et al., “Graphene
oxide-based nanocomposites decorated with silver nanoparti-
cles as an antibacterial agent,” Nanoscale Research Letters,
vol. 13, no. 1, p. 116, 2018.
[33] S. R.-V. Castrillón, F. Perreault, A. F. de Faria, and
M. Elimelech, “Interaction of graphene oxide with bacterial
cell membranes: insights from force spectroscopy,” Environ-
mental Science & Technology Letters, vol. 2, no. 4, pp. 112–
117, 2015.
[34] J. Li, G. Wang, H. Zhu et al., “Antibacterial activity of
large-area monolayer graphene film manipulated by charge
transfer,” Scientific Reports, vol. 4, no. 1, 2015.
[35] J. Chen, H. Peng, X. Wang, F. Shao, Z. Yuan, and H. Han,
“Graphene oxide exhibits broad-spectrum antimicrobial activ-
ity against bacterial phytopathogens and fungal conidia by
intertwining and membrane perturbation,” Nanoscale, vol. 6,
no. 3, pp. 1879–1889, 2014.
[36] S. Saxena, T. A. Tyson, S. Shukla, E. Negusse, H. Chen, and
J. Bai, “Investigation of structural and electronic properties of
graphene oxide,” Applied Physics Letters, vol. 99, no. 1,
pp. 13104–13107, 2011.
[37] C. Gómez-Navarro, R. T. Weitz, A. M. Bittner et al., “Elec-
tronic transport properties of individual chemically reduced
graphene oxide sheets,” Nano Letters, vol. 7, no. 11,
pp. 3499–3503, 2007.
[38] O. Akhavan and E. Ghaderi, “Escherichia coli bacteria reduce
graphene oxide to bactericidal graphene in a self-limiting
manner,” Carbon, vol. 50, no. 5, pp. 1853–1860, 2012.
[39] S. Gurunathan, J. Woong Han, A. Abdal Daye, V. Eppakayala,
and J.-h. Kim, “Oxidative stress-mediated antibacterial activity
of graphene oxide and reduced graphene oxide in Pseudomo-
nas aeruginosa,” International Journal of Nanomedicine, vol. 7,
pp. 5901–5914, 2012.
[40] M. Moldovan, D. Prodan, C. Sarosi et al., “Synthesis,
morpho-structural properties and antibacterial effect of silicate
based composites containing graphene oxide/hydroxyapatite,”
Materials Chemistry and Physics, vol. 217, pp. 48–53, 2018.
[41] K. Prasad, G. S. Lekshmi, K. Ostrikov et al., “Synergic bacteri-
cidal effects of reduced graphene oxide and silver nanoparti-
cles against Gram-positive and Gram-negative bacteria,”
Scientific Reports, vol. 7, no. 1, pp. 1591–1602, 2017.
[42] A. Al-Jumaili, S. Alancherry, K. Bazaka, andM. Jacob, “Review
on the antimicrobial properties of carbon nanostructures,”
Materials, vol. 10, no. 9, 2017.
[43] V. T. H. Pham, V. K. Truong, M. D. J. Quinn et al., “Graphene
induces formation of pores that kill spherical and rod-shaped
bacteria,” ACS Nano, vol. 9, no. 8, pp. 8458–8467, 2015.
[44] X. Zou, L. Zhang, Z. Wang, and Y. Luo, “Mechanisms of the
antimicrobial activities of graphene materials,” Journal of the
American Chemical Society, vol. 138, no. 7, pp. 2064–2077, 2016.
14 Journal of Nanomaterials
